Aura Other Current Liab vs Net Invested Capital Analysis

AURA Stock

USD 8.73 0.16 1.80%

Aura Biosciences financial indicator trend analysis is way more than just evaluating Aura Biosciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Aura Biosciences is a good investment. Please check the relationship between Aura Biosciences Other Current Liab and its Net Invested Capital accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aura Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade Aura Stock refer to our How to Trade Aura Stock guide.

Other Current Liab vs Net Invested Capital

Other Current Liab vs Net Invested Capital Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Aura Biosciences Other Current Liab account and Net Invested Capital. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Aura Biosciences' Other Current Liab and Net Invested Capital is -0.03. Overlapping area represents the amount of variation of Other Current Liab that can explain the historical movement of Net Invested Capital in the same time period over historical financial statements of Aura Biosciences, assuming nothing else is changed. The correlation between historical values of Aura Biosciences' Other Current Liab and Net Invested Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Current Liab of Aura Biosciences are associated (or correlated) with its Net Invested Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Invested Capital has no effect on the direction of Other Current Liab i.e., Aura Biosciences' Other Current Liab and Net Invested Capital go up and down completely randomly.

Correlation Coefficient

-0.03

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Other Current Liab

Net Invested Capital

The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.

Most indicators from Aura Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Aura Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aura Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade Aura Stock refer to our How to Trade Aura Stock guide.The current year's Enterprise Value is expected to grow to about 426.5 M, whereas Selling General Administrative is forecasted to decline to about 12.5 M.

	2021	2022	2023	2024 (projected)
Interest Expense	13K	850K	977.5K	1.0M
Depreciation And Amortization	835K	1.2M	1.3M	1.0M

Interest Expense Depreciation And Amortization

Aura Biosciences fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Net Working Capital
Total Assets		0.88	-0.01	0.9	0.96	-0.76	0.96	0.93	-0.46	-0.91	0.16	0.69	0.93	0.76	0.46	-0.53	1.0	0.73	-0.94	0.96	0.94	-0.94	0.96	0.92	1.0	1.0
Short Long Term Debt Total	0.88		-0.12	0.84	0.9	-0.8	0.9	0.94	-0.12	-0.95	0.11	0.47	0.94	0.89	0.47	-0.73	0.87	0.76	-0.8	0.87	0.91	-0.75	0.9	0.94	0.87	0.87
Other Current Liab	-0.01	-0.12		0.26	-0.03	0.16	-0.03	-0.19	0.32	-0.04	0.12	-0.32	-0.18	0.23	-0.7	-0.24	0.02	0.44	0.05	-0.28	-0.09	0.06	-0.03	-0.1	0.01	0.0
Total Current Liabilities	0.9	0.84	0.26		0.83	-0.51	0.83	0.88	-0.26	-0.81	0.4	0.48	0.88	0.75	0.39	-0.51	0.9	0.76	-0.78	0.78	0.77	-0.77	0.83	0.88	0.9	0.89
Total Stockholder Equity	0.96	0.9	-0.03	0.83		-0.85	1.0	0.86	-0.45	-0.94	0.15	0.74	0.86	0.83	0.37	-0.69	0.96	0.72	-0.98	0.94	0.98	-0.95	1.0	0.84	0.96	0.96
Other Liab	-0.76	-0.8	0.16	-0.51	-0.85		-0.85	-0.68	0.15	0.91	0.36	-0.47	-0.68	-0.85	-0.13	0.79	-0.76	-0.73	0.79	-0.78	-0.92	0.74	-0.85	-0.7	-0.76	-0.76
Net Tangible Assets	0.96	0.9	-0.03	0.83	1.0	-0.85		0.86	-0.45	-0.94	0.15	0.74	0.86	0.83	0.37	-0.69	0.96	0.71	-0.98	0.94	0.98	-0.95	1.0	0.84	0.96	0.96
Property Plant And Equipment Net	0.93	0.94	-0.19	0.88	0.86	-0.68	0.86		-0.28	-0.86	0.17	0.53	1.0	0.73	0.65	-0.48	0.91	0.67	-0.79	0.92	0.85	-0.78	0.86	0.99	0.91	0.91
Net Debt	-0.46	-0.12	0.32	-0.26	-0.45	0.15	-0.45	-0.28		0.14	-0.41	-0.91	-0.27	0.11	-0.52	-0.22	-0.47	0.2	0.61	-0.56	-0.37	0.67	-0.45	-0.17	-0.48	-0.48
Retained Earnings	-0.91	-0.95	-0.04	-0.81	-0.94	0.91	-0.94	-0.86	0.14		0.06	-0.49	-0.87	-0.95	-0.24	0.82	-0.91	-0.87	0.87	-0.86	-0.97	0.82	-0.94	-0.89	-0.91	-0.91
Accounts Payable	0.16	0.11	0.12	0.4	0.15	0.36	0.15	0.17	-0.41	0.06		0.4	0.16	-0.09	0.41	0.11	0.15	-0.2	-0.19	0.13	-0.01	-0.19	0.15	0.08	0.15	0.15
Cash	0.69	0.47	-0.32	0.48	0.74	-0.47	0.74	0.53	-0.91	-0.49	0.4		0.52	0.26	0.55	-0.18	0.69	0.09	-0.84	0.78	0.67	-0.86	0.74	0.43	0.7	0.7
Non Current Assets Total	0.93	0.94	-0.18	0.88	0.86	-0.68	0.86	1.0	-0.27	-0.87	0.16	0.52		0.73	0.64	-0.48	0.91	0.68	-0.79	0.92	0.85	-0.78	0.86	0.99	0.91	0.91
Non Currrent Assets Other	0.76	0.89	0.23	0.75	0.83	-0.85	0.83	0.73	0.11	-0.95	-0.09	0.26	0.73		0.01	-0.93	0.76	0.93	-0.72	0.66	0.86	-0.65	0.83	0.78	0.76	0.76
Other Assets	0.46	0.47	-0.7	0.39	0.37	-0.13	0.37	0.65	-0.52	-0.24	0.41	0.55	0.64	0.01		0.19	0.43	-0.13	-0.37	0.62	0.33	-0.41	0.37	0.55	0.44	0.44
Long Term Debt	-0.53	-0.73	-0.24	-0.51	-0.69	0.79	-0.69	-0.48	-0.22	0.82	0.11	-0.18	-0.48	-0.93	0.19		-0.54	-0.78	0.58	-0.45	-0.73	0.47	-0.69	-0.52	-0.53	-0.53
Cash And Short Term Investments	1.0	0.87	0.02	0.9	0.96	-0.76	0.96	0.91	-0.47	-0.91	0.15	0.69	0.91	0.76	0.43	-0.54		0.74	-0.95	0.95	0.94	-0.95	0.96	0.9	1.0	1.0
Common Stock Shares Outstanding	0.73	0.76	0.44	0.76	0.72	-0.73	0.71	0.67	0.2	-0.87	-0.2	0.09	0.68	0.93	-0.13	-0.78	0.74		-0.61	0.57	0.75	-0.57	0.72	0.76	0.73	0.73
Non Current Liabilities Total	-0.94	-0.8	0.05	-0.78	-0.98	0.79	-0.98	-0.79	0.61	0.87	-0.19	-0.84	-0.79	-0.72	-0.37	0.58	-0.95	-0.61		-0.93	-0.95	0.99	-0.98	-0.76	-0.95	-0.95
Other Current Assets	0.96	0.87	-0.28	0.78	0.94	-0.78	0.94	0.92	-0.56	-0.86	0.13	0.78	0.92	0.66	0.62	-0.45	0.95	0.57	-0.93		0.93	-0.94	0.94	0.89	0.96	0.96
Other Stockholder Equity	0.94	0.91	-0.09	0.77	0.98	-0.92	0.98	0.85	-0.37	-0.97	-0.01	0.67	0.85	0.86	0.33	-0.73	0.94	0.75	-0.95	0.93		-0.92	0.98	0.85	0.94	0.94
Total Liab	-0.94	-0.75	0.06	-0.77	-0.95	0.74	-0.95	-0.78	0.67	0.82	-0.19	-0.86	-0.78	-0.65	-0.41	0.47	-0.95	-0.57	0.99	-0.94	-0.92		-0.95	-0.75	-0.95	-0.96
Net Invested Capital	0.96	0.9	-0.03	0.83	1.0	-0.85	1.0	0.86	-0.45	-0.94	0.15	0.74	0.86	0.83	0.37	-0.69	0.96	0.72	-0.98	0.94	0.98	-0.95		0.84	0.96	0.96
Property Plant And Equipment Gross	0.92	0.94	-0.1	0.88	0.84	-0.7	0.84	0.99	-0.17	-0.89	0.08	0.43	0.99	0.78	0.55	-0.52	0.9	0.76	-0.76	0.89	0.85	-0.75	0.84		0.9	0.9
Total Current Assets	1.0	0.87	0.01	0.9	0.96	-0.76	0.96	0.91	-0.48	-0.91	0.15	0.7	0.91	0.76	0.44	-0.53	1.0	0.73	-0.95	0.96	0.94	-0.95	0.96	0.9		1.0
Net Working Capital	1.0	0.87	0.0	0.89	0.96	-0.76	0.96	0.91	-0.48	-0.91	0.15	0.7	0.91	0.76	0.44	-0.53	1.0	0.73	-0.95	0.96	0.94	-0.96	0.96	0.9	1.0

Click cells to compare fundamentals

Aura Biosciences Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

When determining whether Aura Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aura Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aura Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aura Biosciences Stock:

How To Invest In Aura

Details

Is Aura Stock a good investment?

Details

What is Aura Biosciences' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aura Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade Aura Stock refer to our How to Trade Aura Stock guide.

You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aura Biosciences. If investors know Aura will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aura Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.73)

Return On Assets

(0.30)

Return On Equity

(0.51)

The market value of Aura Biosciences is measured differently than its book value, which is the value of Aura that is recorded on the company's balance sheet. Investors also form their own opinion of Aura Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Aura Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aura Biosciences' market value can be influenced by many factors that don't directly affect Aura Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Aura Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aura Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aura Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Aura Other Current Liab vs Net Invested Capital Analysis

Other Current Liab vs Net Invested Capital

Other Current Liab vs Net Invested Capital Correlation Analysis

Correlation Coefficient

Other Current Liab

Net Invested Capital

Aura Biosciences fundamental ratios Correlations

Aura Biosciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Net Working Capital	+ 1.0	Total Assets
Net Tangible Assets	+ 1.0	Total Stockholder Equity
Net Invested Capital	+ 1.0	Total Stockholder Equity
Net Invested Capital	+ 1.0	Net Tangible Assets

Net Invested Capital	- 0.98	Non Current Liabilities Total
Non Current Liabilities Total	- 0.98	Net Tangible Assets
Non Current Liabilities Total	- 0.98	Total Stockholder Equity
Other Stockholder Equity	- 0.97	Retained Earnings
Net Working Capital	- 0.96	Total Liab
Total Current Assets	- 0.95	Total Liab